Department of Orthopedic Surgery, Shengjing Hospital of China Medical University, ShenYang, Liaoning, China.
Department of Emergency Medicine, Shengjing Hospital of China Medical University, ShenYang, Liaoning, China.
Redox Biol. 2024 Jul;73:103143. doi: 10.1016/j.redox.2024.103143. Epub 2024 Mar 30.
Our previous studies have shown that lipoxin A (LXA) can serve as a potential biomarker for assessing the efficacy of exercise therapy in knee osteoarthritis (KOA), and fibroblast-like synoviocytes (FLSs) may play a crucial role in KOA pain as well as in the progression of the pathology.
By analyzing the GSE29746 dataset and collecting synovial samples from patients with different Kellgren-Lawrence (KL) grades for validation, we focused on exploring the potential effect of LXA on ferroptosis in FLSs through the ESR2/LPAR3/Nrf2 axis to alleviate pain and pathological advancement in KOA.
The association between FLSs ferroptosis and chondrocyte matrix degradation was explored by cell co-culture. We overexpressed and knocked down LPAR3 in vitro to explore its potential mechanism in FLSs. A rat model of monosodium iodoacetate (MIA)-induced KOA was constructed and intervened with moderate-intensity treadmill exercise and intraperitoneal injection of PHTPP to investigate the effects of the LXA intracellular receptor ESR2 on exercise therapy.
ESR2, LPAR3, and GPX4 levels in the synovium decreased with increasing KL grade. After LXA intervention in the co-culture system, GPX4, LPAR3, and ESR2 were upregulated in FLSs, collagen II was upregulated in chondrocytes, and MMP3 and ADAM9 were downregulated. LPAR3 overexpression upregulated the expression of GPX4, Nrf2, and SOD1 in FLSs, while downregulating the expression of MMP13 and MMP3; LPAR3 knockdown reversed these changes. Moderate-intensity platform training improved the behavioral manifestations of pain in KOA rats, whereas PHTPP treatment partially reversed the improvement in synovial and cartilage pathologies induced by platform training.
LXA inhibited FLSs ferroptosis by activating the ESR2/LPAR3/Nrf2 axis, thereby alleviating the pain and pathological progression of KOA. This study brings a new target for the treatment of KOA and also leads to a deeper understanding of the potential mechanisms of exercise therapy for KOA.
我们之前的研究表明,脂氧素 A(LXA)可以作为评估膝骨关节炎(KOA)运动疗法疗效的潜在生物标志物,成纤维样滑膜细胞(FLS)在 KOA 疼痛以及病理进展中可能发挥关键作用。
通过分析 GSE29746 数据集并收集不同 Kellgren-Lawrence(KL)分级患者的滑膜样本进行验证,我们重点探讨了 LXA 通过 ESR2/LPAR3/Nrf2 轴对 FLS 铁死亡的潜在影响,以减轻 KOA 的疼痛和病理进展。
通过细胞共培养探索 FLS 铁死亡与软骨细胞基质降解的关系。我们在体外过表达和敲低 LPAR3,以探讨其在 FLS 中的潜在机制。构建了 MIA 诱导的 KOA 大鼠模型,并进行了中等强度跑步机运动和腹腔注射 PHTPP 的干预,以研究 LXA 细胞内受体 ESR2 对运动疗法的影响。
KL 分级越高,滑膜中 ESR2、LPAR3 和 GPX4 的水平越低。在共培养系统中加入 LXA 干预后,FLS 中 GPX4、LPAR3 和 ESR2 上调,软骨细胞中胶原 II 上调,MMP3 和 ADAM9 下调。LPAR3 过表达上调 FLS 中 GPX4、Nrf2 和 SOD1 的表达,下调 MMP13 和 MMP3 的表达;LPAR3 敲低则逆转了这些变化。中等强度平台训练改善了 KOA 大鼠的疼痛行为表现,而 PHTPP 处理部分逆转了平台训练诱导的滑膜和软骨病理改善。
LXA 通过激活 ESR2/LPAR3/Nrf2 轴抑制 FLS 铁死亡,从而缓解 KOA 的疼痛和病理进展。这项研究为 KOA 的治疗带来了新的靶点,也使我们对运动疗法治疗 KOA 的潜在机制有了更深入的理解。